Actos 'Most Substantial' Factor In Man's Cancer, Doc Testifies

Law360, Los Angeles (March 26, 2013, 3:33 PM EDT) -- Takeda Pharmaceutical Co.’s diabetes drug Actos was “the most substantial causative factor” in a California man’s terminal bladder cancer, a urologist testifying for the plaintiff told a Los Angeles jury Tuesday in the first product liability trial of its kind.

Dr. Norm D. Smith, an associate professor of surgery and urology at the University of Chicago Medical Center, testified Tuesday that plaintiff Jack Cooper's taking of Actos from 2006 to 2011 was the primary reason he became ill.

Smith told jurors under direct examination by plaintiffs...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.